Reports on HIV/AIDS: 1990

NOVEMBER 30, 1990, MMWR, Vol. 39, RR-16 [inclusive page numbers]
21. Munoz A, Carey V, Saah A, et al. Predictors in the decline in CD4 lymphocytes in a cohort of
homosexual partners infected with the human immunodeficiency virus. J Acquir Immune
Defic Syndr 1988;1:396-404.
22. DeGruttola V, Lange N, Dafni U. Modeling the progression of HIV infection. Proceedings
from the 47th session of the International Statistics Institute, Paris, August 1989.
23. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of HIV type 1 infection and the
development of AIDS in subjects with hemophilia. N Engl J Med 1989;321:1141-8.
24. Brookmeyer R, Liao J. Statistical modelling of the AIDS epidemic for forecasting health care
needs. Biometrics 1990;46:1151-63.
25. Longini IM, Clark WS, Byers RN, et al. Statistical analysis of the stages of HIV infection using
a Markov model. Stat Med 1989;8:831-43.
26. Longini IM, Byers RH, Tan WY. Estimating the stage-specific numbers of HIV infection using
the back-calculation method. Presented at the 1990 Joint Statistical Meetings of the
American Statistical Association, Anaheim, California, Aug 6-9, 1990.
27. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive
cells per cubic millimeter. N Engl J Med 1990;322:941-9.
28. Holmberg SD, Harrison JS, Buchbinder SP, et al. Therapeutic and prophylactic drug use by
homosexual and bisexual men in three U.S. cities [Abstract S.D.790]. Final Program and
Abstracts. VI International Conference on AIDS. University of California at San Francisco,
1990;3:287.
29. Lang W, Samuel M, Osmond D, Krampf W, Moss A, Shrager L. Population based estimates
of zidovudine and aerosol pentamidine use in San Francisco, 1987-89 [Abstract S.D.788].
Final Program and Abstracts. VI International Conference on AIDS. University of California at
San Francisco, 1990;3:287.
30. Lai KK. Acceptance rate of zidovudine among HIV-infected persons with 500<CD4>200
[Abstract S.D.776]. Final Program and Abstracts. VI International Conference on AIDS.
University of California at San Francisco, 1990;3:284.

164